![Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine](https://www.thelancet.com/cms/attachment/cb984d9d-5c81-463d-b03e-3d380f9c4749/fx1_lrg.jpg)
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine
![PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4a8c77ff85aa1fdad67620b0aea7f1405127ed2/9-Figure1-1.png)
PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar
![Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/45/11/1557/F1.large.jpg)
Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology
![Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage](https://www.mdpi.com/biomolecules/biomolecules-10-01641/article_deploy/html/images/biomolecules-10-01641-g001-550.jpg)
Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
![Utilisation clinique du dosage du complément. En dosant le C3 et le C4... | Download Scientific Diagram Utilisation clinique du dosage du complément. En dosant le C3 et le C4... | Download Scientific Diagram](https://www.researchgate.net/publication/335170865/figure/fig2/AS:791846506737664@1565802327402/Utilisation-clinique-du-dosage-du-complement-En-dosant-le-C3-et-le-C4-plusieurs-cas-de_Q640.jpg)
Utilisation clinique du dosage du complément. En dosant le C3 et le C4... | Download Scientific Diagram
![Low Levels of Complement Factor C4 Not Always Implicate Disease Activity in Systemic Lupus Erythematosus Low Levels of Complement Factor C4 Not Always Implicate Disease Activity in Systemic Lupus Erythematosus](https://www.scirp.org/html/paperimages/28159_2.jpg)
Low Levels of Complement Factor C4 Not Always Implicate Disease Activity in Systemic Lupus Erythematosus
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium | PLOS ONE
![Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation | BMC Nephrology | Full Text Case report: lupus nephritis with autoantibodies to complement alternative pathway proteins and C3 gene mutation | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-015-0032-6/MediaObjects/12882_2015_32_Fig1_HTML.gif)